ITGD.F logo

Integral Diagnostics OTCPK:ITGD.F Stock Report

Last Price

US$2.10

Market Cap

US$372.2m

7D

0%

1Y

n/a

Updated

04 Aug, 2024

Data

Company Financials +

Integral Diagnostics Limited

OTCPK:ITGD.F Stock Report

Market Cap: US$372.2m

ITGD.F Stock Overview

A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. More details

ITGD.F fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends2/6

My Notes

Capture your thoughts, links and company narrative

Integral Diagnostics Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Integral Diagnostics
Historical stock prices
Current Share PriceAU$2.10
52 Week HighAU$2.10
52 Week LowAU$0.95
Beta0.75
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-4.98%

Recent News & Updates

Recent updates

Shareholder Returns

ITGD.FUS HealthcareUS Market
7D0%-1.0%-2.7%
1Yn/a-10.2%23.4%

Return vs Industry: Insufficient data to determine how ITGD.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how ITGD.F performed against the US Market.

Price Volatility

Is ITGD.F's price volatile compared to industry and market?
ITGD.F volatility
ITGD.F Average Weekly Movementn/a
Healthcare Industry Average Movement7.6%
Market Average Movement6.3%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: ITGD.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine ITGD.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
19672,010Ian Kadishwww.integraldiagnostics.com.au

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.

Integral Diagnostics Limited Fundamentals Summary

How do Integral Diagnostics's earnings and revenue compare to its market cap?
ITGD.F fundamental statistics
Market capUS$372.17m
Earnings (TTM)-US$37.72m
Revenue (TTM)US$297.54m

1.3x

P/S Ratio

-9.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ITGD.F income statement (TTM)
RevenueAU$456.31m
Cost of RevenueAU$307.71m
Gross ProfitAU$148.60m
Other ExpensesAU$206.46m
Earnings-AU$57.85m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Aug 27, 2024

Earnings per share (EPS)-0.25
Gross Margin32.57%
Net Profit Margin-12.68%
Debt/Equity Ratio73.3%

How did ITGD.F perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

-24%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/08/04 08:28
End of Day Share Price 2024/05/07 00:00
Earnings2023/12/31
Annual Earnings2023/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Integral Diagnostics Limited is covered by 24 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Russell WrightBarclay Pearce Capital Pty Limited
Thomas YeoBarrenjoey Markets Pty Limited
Saul HadassinBarrenjoey Markets Pty Limited